- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
- Types of NHL
Lymphoma and Pets
FDA Approves First Human Trials With Embryonic Stem Cells
Various experts have been debating the merits of ASCs and ESCs for a long time now, but one aspect of the FDA’s announcement can’t be overlooked: Less than 5% of adult cancer patients take part in clinical trials in the United States. If any clinical trial at all is going to be effective, it needs participants.
For this reason, back in October of 2007 the Leukemia & Lymphoma Society and the Cleveland Clinic Taussig Cancer Institute got together and launched the Clinical Trial Center for Hematologic Malignancies. The goal of the Center is to make participation in important clinical trials easier by overcoming common obstacles such as patient reluctance and difficult travel requirements.
For more information, either:
Call the Taussig Institute’s Cancer Answer Line at (866) 223-8100, or
Go to the Taussig Institute’s home page at http://cms.clevelandclinic.org/cancer/